InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Explore the complete record of transactions filed by Singh Prabhdeep, Directeur de la Croissance. Director active across 1 company, notably Clover Health Investments, CORP. /de. In total, 3 reports have been logged. History available since 8 July 2021. The latest transaction was filed on 16 September 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Singh Prabhdeep
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报3 总计
353,356 股0Class A Common StockSEC:0001628280-22-025242:0
255,474 股0Class A Common StockSEC:0001628280-22-006433:0
211,193 股0Class A Common StockSEC:0001209191-21-046356:0
3 条申报中的 3 条
About Singh Prabhdeep
Prabhdeep Singh serves as Chief Growth Officer at CLOVER HEALTH INVESTMENTS, CORP. In this role, he is responsible for developing and implementing strategies to drive the company's growth. His expertise in business development and market strategy allows him to play a key role in expanding CLOVER HEALTH's operations. He collaborates closely with other executives to identify new growth opportunities.
